Isolation of rare circulating tumour cells in cancer patients by microchip technologySunitha Nagrath, Mehmet Toner, Lecia V. Sequist et al.|Nature|2007Cited by 3.5k
Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 studyCharles J. Ryan, Dana E. Rathkopf, Matthew R. Smith et al.|The Lancet Oncology|2015Cited by 1.4k
RNA-Seq of single prostate CTCs implicates noncanonical Wnt signaling in antiandrogen resistanceDavid T. Miyamoto, Daniel A. Haber, Yu Zheng et al.|Science|2015Cited by 718
Isolation and Characterization of Circulating Tumor Cells from Patients with Localized and Metastatic Prostate CancerShannon L. Stott, Shyamala Maheswaran, Richard J. Lee et al.|Science Translational Medicine|2010Cited by 537
Niraparib and Abiraterone Acetate for Metastatic Castration-Resistant Prostate CancerKim N., Celio Kussumoto, Dana E. Rathkopf et al.|Journal of Clinical Oncology|2023Cited by 317